IRIS
DAMIANI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.798
AS - Asia 5.552
EU - Europa 4.733
SA - Sud America 1.161
AF - Africa 92
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 4
Totale 26.355
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.600
SG - Singapore 2.537
UA - Ucraina 1.539
CN - Cina 1.372
BR - Brasile 965
DE - Germania 775
HK - Hong Kong 679
FI - Finlandia 555
IT - Italia 465
RU - Federazione Russa 375
SE - Svezia 321
VN - Vietnam 297
IE - Irlanda 253
KR - Corea 157
GB - Regno Unito 144
TR - Turchia 141
CA - Canada 140
FR - Francia 118
IN - India 98
AR - Argentina 66
BD - Bangladesh 44
IQ - Iraq 40
MX - Messico 38
CO - Colombia 36
PL - Polonia 32
IR - Iran 29
EC - Ecuador 28
ZA - Sudafrica 26
JP - Giappone 25
CZ - Repubblica Ceca 24
NL - Olanda 20
ID - Indonesia 18
MA - Marocco 18
BE - Belgio 17
PK - Pakistan 17
AT - Austria 16
PY - Paraguay 16
UZ - Uzbekistan 16
VE - Venezuela 15
EU - Europa 13
ES - Italia 11
TG - Togo 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
RO - Romania 10
CL - Cile 9
EG - Egitto 9
JO - Giordania 9
SA - Arabia Saudita 9
BG - Bulgaria 8
RS - Serbia 8
AZ - Azerbaigian 7
IL - Israele 7
KZ - Kazakistan 7
PE - Perù 7
BO - Bolivia 6
CH - Svizzera 5
KE - Kenya 5
KG - Kirghizistan 5
LT - Lituania 5
TN - Tunisia 5
BH - Bahrain 4
DZ - Algeria 4
HN - Honduras 4
HU - Ungheria 4
JM - Giamaica 4
OM - Oman 4
AL - Albania 3
AO - Angola 3
AU - Australia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
LB - Libano 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
CR - Costa Rica 2
GA - Gabon 2
GL - Groenlandia 2
KW - Kuwait 2
LU - Lussemburgo 2
ML - Mali 2
NO - Norvegia 2
NP - Nepal 2
RW - Ruanda 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
EE - Estonia 1
GM - Gambi 1
Totale 26.340
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.113
Ann Arbor 1.688
Fairfield 1.222
Houston 1.188
Jacksonville 1.105
Singapore 1.035
Beijing 812
Ashburn 788
Chandler 762
Hong Kong 678
Dearborn 590
Wilmington 505
Seattle 447
Cambridge 374
Boardman 301
Princeton 252
Dublin 251
Los Angeles 194
Dallas 169
Seoul 146
Hefei 142
Buffalo 126
Udine 112
Izmir 110
Munich 110
Ho Chi Minh City 105
San Diego 102
São Paulo 80
New York 77
Ottawa 77
Ogden 62
Hanoi 58
Trieste 58
Norwalk 56
Turku 46
Redondo Beach 45
Santa Clara 45
Des Moines 39
Nanjing 35
Rio de Janeiro 35
Mumbai 30
Helsinki 29
Regensburg 29
Warsaw 29
Kunming 28
Montreal 27
Dong Ket 25
Phoenix 25
Tokyo 24
Porto Alegre 23
Toronto 23
Belo Horizonte 22
Guangzhou 21
Simi Valley 19
Stockholm 19
Augusta 18
Brasília 18
London 18
Boston 17
Brussels 17
Poplar 17
Atlanta 16
Denver 16
Jinan 16
Mexico City 16
Rome 16
Andover 15
Tashkent 15
Washington 15
Baghdad 14
Bogotá 14
Johannesburg 14
Leawood 14
Nanchang 14
Orem 14
Brooklyn 13
Curitiba 13
Milan 13
Campinas 12
Chennai 12
Chicago 12
Nuremberg 12
San Francisco 12
San Mateo 12
Frankfurt am Main 11
Fuzhou 11
Lomé 11
Monmouth Junction 11
Brno 10
Caxias do Sul 10
Da Nang 10
Guarulhos 10
Manchester 10
Quito 10
Salvador 10
Amman 9
Ankara 9
Asunción 9
Dhaka 9
Grafing 9
Totale 17.097
Salva come PNG Salva come JPEG
Nome #
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy 270
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 214
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 201
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non MDR cells to different anthracycline derivatives 188
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 185
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 180
“Fibre nervose peptidergiche intraepidermiche: uno studio immunoistochimico”. 179
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 176
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 170
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 167
Histone post-translational modifications associated to BAALC expression in leukemic cells. 163
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells 163
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 157
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission 155
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 155
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. 154
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome 153
Clinical feature and outcome in seven patients wuth hyaline or mixed variant of Castleman’s disease. A single centre experience 150
Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome. 150
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia 150
A mutational status of IGVH genes consisten with antigen-driven selection has prognostic impact istead of percento f mutations in B-cell chronic lymphocytic leukemia 149
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 147
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia 145
A study of the material in the ATLAS inner detector using secondary hadronic interactions 144
“Overexpression of multidrug resistance-associated P-170 glycoprotein in acute non lymphocytic leukemia”. 142
Suggestive evidence for a Microanatomical Relationship betweeb Mast Cells and Nerve Fibres Containing Substance P, Calcitonin Gene Related Peptide, Vasoactive Intestinal Polypeptide, and Somatostatin in the rat Mesentery. 142
Multipotent Mesenchymal Stem Cells Can Be Isolated and Grown from Many Tissues (Bone Marrow, Liver and Heart) 142
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 141
5-AZACITIDINE FIVE DAYS/MONTHLY SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC (MDS) PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS Authors 140
Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-hematologic diseases. 140
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia 140
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 139
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera. 139
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML 139
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 138
Unexpected phenotype of a typical NPM1 mutant 138
Granulocyte-macrophage colony -stimulating factor in acute nonlymphocytic leukemia before and after chemo therapy”. 137
Visualization of PGP 9.5 immunoreactive nerve terminals in the mouse snout epidermis. 136
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 years treated with induction regimens including fludarabine: retrospective analysis of 224 cases 135
“Long Term Follow-up of the Italian Trial of Interferon-a Versus Conventional Chemotherapy in Chronic Myeloid Leukemia”. 134
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 133
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. 133
“D-Verapamil downmodulates P-170 associated resistance to doxorubicin, daunorubicin and idarubicin”. 131
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 131
Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression 131
FEASIBILITY OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH CD34 SELECTED STEM CELLS: OUTCOME AND IMMUNOLOGICAL COMPLICATIONS 130
Acute promyelocytic leucemia: low expression of multidrug resistance phenotype at onset suggest a favourable effect of gentuzumab ozogamicyn (CMA-676 129
The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia. 129
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias 129
Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. 128
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement 128
A simple Prognostic Scoring System for newly diagnosed acute leukaemia patients with normal karyotype: a retrospective analysis on 173 cases. 127
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 127
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 127
“CD34+ selected versus un-manipulated autologous stem cell transplantation in multiple myeoloma: impact on dendritic and immune recovery and on complications due to infections”. 125
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 125
Dendritic cell recovery after autologous stem cell transplantation 125
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 125
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 125
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 125
Acute promyelocyttic leucemia: low expression of multidrug resistance phenotype at onset suggests a favorable effect of Gemtuzumab Ozogamycin (CMA 676) 124
CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis”. 123
KIR POLYMORPHISM IN REDUCED INTENSITY HLA-ID SIBLING STEM CELL TRANSPLANTATION: IMPACT ON CLINICAL OUTCOME 123
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia. 123
“Espressione dell’antigene CD34 nei tessuti normali e patologici e possibili applicazioni cliniche delle cellule CD34”. 122
ABCB1 (PGP) and ABCG (BCRP) proteins are independent prognostic factors for complete remissione and relapse risk, respectively in normal karyotype adult de novo acute myeloid leukemia. 122
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 122
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 122
Flow cytometry evaluation of plasma cells contaminating leukapheresis pre- and post- CD34-positive selection- 121
“Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas”. 121
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 121
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults. 119
“Case report: mdr-1 gene amplification in acute lymphoblastic leukemia prior to antileukemic treatment”. 119
Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells. 117
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients 117
Peripheral blood stem cell mobilization in multiple myeloma: advantage of 7 vs. 4 g/m2 cyclophosfamide on stem cell quality and plasma cell mobilization. 116
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. 115
Serotoninergic fibres form dense synaptic contacts with Purkinje cells in the mouse cerebellar cortex--an immunohistochemical study 115
DENDRITIC CELL RECOVERY AFTER AUTOLOGOUS AND ALLOGENEIC TRANSPLANTATION 114
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. 114
Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia 114
Prognostic factors anad expression of multidrug-resistance related proteins in 36 patients with acute promyelocytic leukemia. 113
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse 113
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias 112
Allogeneic stem cell transplantation as salvage therapy for patients with lymphoma. 112
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) in de novo adult acute lymphoblastica leukemia 111
Cytokines dysregulation and chronic graft versus host disease after allogeneic haematopoieitc stem cell transplantation with reduced intensity conditioning 111
“Expression of Multidrug resistance gene (MDR 1) in normal hematopoietic cells”. 111
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 111
Proliferation and maturation effects of in vivo granulo-monocyte colony stimulating factor in acute non-lymphocytic leucemia”. 110
Castleman's disease: an unusual cause of mediastinal mass and anemia. 110
A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of aurtologoaus stem cell transplantation in first remission on autcome 110
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation 109
“Treatment of Ph+ chronic myeloid leukemia by gamma interferon”. 109
Sequential study of cytokine and lymphocyte patterns in patients with chronic agraft versus host disease after reduced intensity conditioning allogenic stem cell transplantation 108
Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis 108
Isolation, characterization and in vitro growth of human multipotent adult cardiac progenitor cells 108
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia. 107
High dose therapy with stem cell rescue in elderly atients with aggressive poor risk lymphomas: a review of 14 cases. 107
A SIMPLE PROGNOSTIC SCORING SYSTEM FOR NEWLY DIAGNOSED ACUTE LEUKAEMIA PATIENTS WITH NORMAL KARYOTYPE: A RETROSPECTIVE ANALYSIS ON 420 CASES 107
Totale 13.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.925
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.965 0 0 0 0 0 404 154 343 493 68 414 89
2021/20221.898 53 276 69 167 64 47 78 103 19 311 396 315
2022/20231.861 273 97 16 226 188 519 6 149 254 31 57 45
2023/2024600 98 58 35 27 71 84 10 33 86 44 13 41
2024/20254.435 87 346 209 117 140 187 262 285 476 247 867 1.212
2025/20264.196 704 779 644 733 1.087 249 0 0 0 0 0 0
Totale 26.707